Skye Bioscience Investor Call
Wed, 11 Oct
|Zoom Call
We have are transitioning our investor lunch to a group call to accommodate participants. Skye Bioscience CEO Punit Dhillon and CSO and CSO Chris Twitty will discuss the company's recent transformational transactions and outlook.
Time & Location
11 Oct 2023, 13:00 – 14:00
Zoom Call
Guests
About The Event
Skye Bioscience Inc.
OTC:SKYED
Market Cap: $40.1M
Speakers
Punit Dhillon, CEO
Chris Twitty, CSO
Skye Bioscience has recently completed a restructuring and rebrand, financed by 5AM Ventures, Versant Ventures including a $17M financing and acquisition of two Phase 2 pharmaceuticals targeting the endocannabinoid system to treat inflammatory, fibrotic, and metabolic diseases.
Join Us October 11th for a private investor call with CEO Punit Dhillon and CSO Chris Twitty to hear about the company's recent transformational transactions and outlook.